<DOC>
	<DOCNO>NCT00159159</DOCNO>
	<brief_summary>Primary Objective : - Evaluation benefit renal function one year low dose ciclosporine versus usual dose Secondary Objective : - To evaluate immunosuppressive efficacy tolerance treatment Study Duration : Twelve month patient Study Treatment : Ciclosporine Group A : low dose &gt; = 130 µg/l &lt; T0 ciclosporinemia &lt; 200 µg/l ; Group B : standard dose &gt; = 200 µg/l &lt; T0 ciclosporinemia &lt; 300 µg/l . Study Visits : One visit every 15 day , first three month ; 1 visit every month , 6 month ; 1 visit 9 12 month . Associated Treatments : - Mycophenolate ( Cellcept® ) , 3g day - Corticoids , use transplanted patient Randomization : Randomization occur decide ciclosporine introduce .</brief_summary>
	<brief_title>LOW CYCLO : Study Evaluating Benefit Two Doses Ciclosporine de Novo Cardiac Transplant</brief_title>
	<detailed_description />
	<criteria>Recipient : Males female , age &gt; 18 &lt; 65 . First cardiac transplant . Negative pregnancy test female childbearing potential , screen . Efficient method contraception must use study . Written informed consent . Donor : Cold ischemia duration &lt; 6 hour Recipient : Unstable hemodynamic status randomization . Patient assist circulation , consider unstable . Serum creatinine &gt; 250 µmol/l . Nursing pregnant female . HIV positive . PCR hepatitis C virus ( HCV ) positive hepatitis B surface ( Hbs ) antigen positive ( within 6 month prior study ) . Multiorgan graft retransplant . History cancer ( evolve , within 5 year , except epidermoid basocellular localise cutaneous carcinoma ) . Use investigational product and/or participation another clinical research study within last 30 day prior study entry . Any substance abuse psychiatric disorder Contraindication study treatment . Unable introduce ciclosporine within 4 day transplant . Donor : Known coronary pathology cardiac disease . HBsAg positive HCV positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Cardiac Transplant</keyword>
	<keyword>ciclosporine</keyword>
	<keyword>immunosuppressive</keyword>
</DOC>